RSS   Newsletter   Contact   Advertise with us
Post Online Media

Enzymotec CEO Ariel Katz to leave

EnzymotecEnzymotec, a supplier of specialty lipid-based products and solutions, announced that Ariel Katz, the company’s president and chief executive officer, will depart the company by the end of May 2017.

Dr. Katz joined Enzymotec in August 2000 as President and Chief Executive Officer. He has also headed our VAYA Pharma segment since January 2012.

Prior to joining Enzymotec, Dr. Katz held various positions with the Dead Sea Bromine Group of Israel Chemicals Ltd. for 14 years, including senior positions in research and development, plant management, marketing and business development.

Dr. Katz holds a bachelor’s degree in chemistry and an M.Sc. in economic management both from Ben-Gurion University of the Negev, Beer Sheva, Israel, and a PhD in engineering in the field of artificial intelligence from Exeter University, UK.

From 2003 until 2010 Dr. Katz was a guest lecturer in the Biotechnology Department in the Technion - Israel Institute of Technology, Haifa, Israel.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy